Dr. Kelley joins our surgical faculty after serving as the Medical Director of Oncology at CHI Memorial Hospital in Chattanooga, TN. He previously served VUMC for several years as Associate Professor and Division Chief of Surgical Oncology and Endocrine Surgery.
Dr. Kelley’s research interests include quality improvement and clinical outcomes research in melanoma and breast cancer, clinical trials of lymph node management in melanoma and breast cancer, and tissue acquisition and analysis for personalized cancer therapy . His recently published articles include Immune responses to BRAF targeted therapy in melanoma: Is targeted therapy immunotherapy? Critical Reviews in Oncogenesis; Melanoma-Specific MHC-II Expression Represents a Tumor-Autonomous Phenotype and Predicts Response to Anti-PD-1/PD-L1 Therapy. Nature Communications; and Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma. Cell.
Vanderbilt Medical Group General Surgery
2105 Edward Curd Lane
Franklin, TN 37067